Description

Sign up or Log In

Sign up for free guest access to view investment ideas with a 45-day delay and read the full report.

Log in to read the full report.

show sort by

You are not eligible to view 18 messages. To gain access to more recent message posts signup free for membership.

#	AUTHOR DATE SUBJECT
27	member 10/03/22 7:26PM Re: Re: Re: Re: Re: Trial news 20
You say "you have very high odds here. say 90% the eventual fine is sub $500m..." I want to believe, but how can you possibly get conviction in that 90% figure? I'm not a lawyer, so... login to read the rest view available tags
25	member 9/21/22 11:52AM Interesting footage from the Sterigenics Cook County trial courtroom
view available tags
19	member 9/19/22 1:26PM Re: Re: Re: Trial news 18
cnm3d wrote this in previous comment: having said all of that... this is going to be a tall order for plaintiffs to prove with any frequency. remember Merck losts its first Vioxx lawsuit for like... login to read the rest 2 view available tags
18	member 9/19/22 1:10PM Re: Re: Trial news 17
Even if the judge reduces this significantly this is one of hundreds of similar cases - pretty scary. Is this even investable at this point? view available tags
17	member 9/19/22 12:56PM Re: Trial news 15
Barclays wrote this over the weekend....they were thinking $100-300mm for total settlement vs. the $363mm that jury is awarding to the Susan Kamoda in this first case.... The key will be how much does that $363mm 1 view available tags
15	member 9/19/22 12:48PM News
Is this just a single case? I'm a bit confused. https://www.chicagotribune.com/news/environment/ct-sterigenics-verdict-20220919-hlu7zoytabcdhe2nvuze7spmny-story.html view available tags
13	member 9/07/22 6:28PM Re: GC resigns in the middle of the trials 12
Based on LinkedIn the guy was only in the company for 11 months - shit happens. Do you really think this reflects on the trials in any way? view available tags
12	member 9/07/22 12:59PM GC resigns in the middle of the trials
Troubling, maybe just tired of the work grind Terrence Hammons Transition On August 31, 2022, the board of directors of Sotera Health Company (the “Company” and the “Board”) accepted Terrence Hammons’ resignation from his position as Senior Vice President, General... login to read the rest view available tags
11	member 7/21/22 2:59AM Re: Re: Re: SHC litigation - anyone following? 10
Adding some useful links: Heatmap of EtO sites: https://projects.propublica.org/toxmap/ EPA IRIS: https://www.epa.gov/iris (the legal EtO threshold framework) ATSDR Letter from 2018: https://www.atsdr.cdc.gov/HAC/pha/sterigenic/Sterigenics_International_Inc-508.pdf ATSDR peer review on EtO: https://www.atsdr.cdc.gov/sites/peer_review/docs/dispsition_of_peer_reviewer_comments_tto_tp.pdf and data provided by the Company: https://investors.soterahealth.com/ethylene-oxide-eo-overview 1 view available tags
9	member 7/20/22 12:03AM Re: SHC litigation - anyone following? 8
Still follow this one, in PA though, let's follow the litigation view available tags
7	member 3/07/22 3:46AM Re: Re: Re: Are the lawsuits what is going to move this stock? 6
Clearly, very hard to say how the situation in Russia/Ukraine will evolve. Co-60 is crucial for the sterilization industry, so one would like to believe that it would be exempt from any sanctions. yet, in the... login to read the rest view available tags
6	member 3/06/22 10:15PM Re: Re: Are the lawsuits what is going to move this stock? 5
Do you think Russian supply of Co-60 an issue beyond 2022? view available tags
5	member 10/31/21 3:46AM Re: Are the lawsuits what is going to move this stock? 3
Regarding your comment “cases can become 30,000 cases quickly and then you're looking at a multibillion dollar settlement”: It is important to understand that EO evaporates in a short radius from the facility (less than... login to read the rest view available tags
4	member 10/29/21 12:37PM Re: Are the lawsuits what is going to move this stock? 3
I have this in (relatively) small size, think stock moves on litigation / secondary (initial pressure vs. overhang removal) view available tags
2	member 10/26/21 1:44AM Re: Growth vs. Steris AST and Other Questions 1
Thank you for the questions Jumbos. We look at performance on a 2yr comp basis and see STE did 12.6%, vs. SHC at 8%. Adjusting for STE’s lab business within the ATS segment we think the... login to read the rest 3 view available tags

load more messages

			2021	2022
Price:	25.91	EPS	0.89	1.05
Shares Out. (in M):	280	P/E	29.1	24.7
Market Cap (in $M):	7,255	P/FCF	46	29.3
Net Debt (in $M):	1	EBIT	418	480
TEV (in $M):	8	TEV/EBIT	21.5	18.7

Description

Sign up or Log In

Sign up for free guest access to view investment ideas with a 45-day delay and read the full report. Log in to read the full report.

Sign up for free guest access to view investment ideas with a 45-day delay and read the full report.

Log in to read the full report.